Cart
sales@molnova.com
Mogroside VIA
CAS No. 2146088-13-1
Mogroside VIA( ——— )
Catalog No. M38953 CAS No. 2146088-13-1
Mogroside VI A, an isomer of Mogroside VI isolated from Luo Han Guo, exerts sweetness property. Mogroside VI A can be used for sweetener and/or taste modifier research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1408 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMogroside VIA
-
NoteResearch use only, not for human use.
-
Brief DescriptionMogroside VI A, an isomer of Mogroside VI isolated from Luo Han Guo, exerts sweetness property. Mogroside VI A can be used for sweetener and/or taste modifier research.
-
DescriptionMogroside VI A, an isomer of Mogroside VI isolated from Luo Han Guo, exerts sweetness property. Mogroside VI A can be used for sweetener and/or taste modifier research.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2146088-13-1
-
Formula Weight1449.588
-
Molecular FormulaC66H112O34
-
Purity>98% (HPLC)
-
SolubilityDMSO : 15 mg/mL (10.35 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. omila Charan, et al. Mogroside Via1, New Isomer of Mogroside VI Isolated From Luo Han Guo. IOSR Journal of Applied Chemistry (IOSR-JAC).
molnova catalog
related products
-
Oxypeucedanin methan...
(+)-Oxypeucedanin methanolate (compound 9) is a natural compound with inhibitory effect on prostaglandin E2 production.
-
TAT-amide TFA (69722...
TAT-amide TFA is a cell penetrating peptide. The cell - penetrating peptides (CPPs) is a kind of access to the short amino acid sequence of different cells.
-
Collagen proline hyd...
Collagen proline hydroxylase inhibitor-1 exhibits antifibroproliferative activity.
